Characterization of binding sites for [3H]-DTG, a selective sigma receptor ligand, in the sheep...
-
Upload
pedro-abreu -
Category
Documents
-
view
212 -
download
0
Transcript of Characterization of binding sites for [3H]-DTG, a selective sigma receptor ligand, in the sheep...
Vol. 171, No. 2, 1990
September 14, 1990
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Pages 8~5881
CHARACTERIZATION OF BINDING SITES FOR L3Hl-DTG, A SELECTIVE SIGMA RECEPTOR LIGAND, IN THE SHEEP PINE&L GLAND
Pedro Abreu and David Sugden
Biomedical Science Division, King's College London, Campden Hill Road,
Kensington, London W8 7AH.U.K.
Received July 25, 1990
Sp5cific binding sites for 13H)-1,3 di-ortho-tolylguanidine (I HI-DTG), a selective radiolabeled sigma receptor ligand, were detected an 4 characterized in sheep pineal gland membranes. The binding of [ HI-DTG with rate
to sheep pineal membranes was rapid and reversibly
-la constant for
.min association (K+,) at 25 C of-y.0052 nM
and rate constant for dissociation (K (K /K+,) of 9.9 nM. S t
) 0.0515 min , gfving a
%nds -' a uration studies dLmonstrated that I HI-DTG
to a single class of sites with an affinity constant 27 + 3.4 nM, and a total binding capacity (B
(Kd) of
pmol/mg protein. Competition ) of 1.39 + 0.03
experiments showed the relative order of potency of compounds for inhibition of
g!%t [ HI-DTG binding to
sheep pineal membranes was as follows: trifluoperazine = DTG> haloperidol> pentazocine> (+)-3-PPP > (+/-)SKF 10,047. Some steroids (testosterone, progesterone, deoxycorticosterone) previously reported to bAnd to the sigma site in brain membranes were very weak inhibitors
[ HI-DTG binding in the present study. The ?H 1 -DTC
results indicate that 1 binding sites having the characteristics of sigma receptors
are present in sheep pineal gland. The physiological importance of these sites in regulating the synthesis of the pineal hormone melatonin awaits further study. @1990 Academic Press, Inc.
In the pineal gland, noradrenaline released at night from
sympathetic fibres innervating the gland, activates both 5-
and
B-adrenoceptors to induce serotonin N-acetyltransferase (sNAT)
activity, the rate-limiting enzyme in the synthesis of the pineal
hormone melatonin (1). In addition to these adrenergic receptors
various other receptors have been described in this tissue. Receptors
for vasoactive intestinal polypeptide (VIP) are present and their
activation elevates intracellular cyclic AMP leading to an induction
of sNAT activity (2,3). Other receptors have been described using
techniques including dopaminergic D2 (4),adenosine
(6) and benzodiazepine receptors (7). However the
radioligand binding
A2 (5), muscarinic
OOU6-291X/90 $1.50
875
Copyright 0 1990 by Academic Press, Inc. All rights of reproduction in any form reserved.
Vol. 171, No. 2, 1990 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
importance of these sites in regulating pineal physiology is not
known.
The present study identifies and characterizes binding sites in the
sheep pineal gland for [3H1-l,3-di-o-tolylguanidine (t3~1-~T~), a
selective ligand for sigma receptors (8). The site selectively
labelled by L3Hl-DTG is the high affinity, naloxone-insensitive site
previously identified in brain using the synthetic sigma opiate drug
[3H]-(+)-N-allylnormetazocine (SKF 10,047) (9) and L3Hl-(+)-3-
(3-hydroxyphenyl)-N-(l-propyl)piperidine ((+)-3-PPP) (10). The study
was prompted by recent autoradiographic data describing a particularly
high density of sigma receptors in the rat pineal gland in comparison
with rat brain (11) and is part of a continuing effort to identify the
receptor sites present on pineal ocytes and to understand their role in
regulating melatonin synthesis.
MATERIALS AND METHODS
1,3-Di-o-tolylguanidine,di-[p-ring-3Hl-, (L3~l-~~~, 52.3 Ci/mmol) was purchased from DuPont (Stevenage, Hertfordshire, U.K.). Drugs were obtained from Sigma Chemical Company (Poole, Dorset, U.K.) and Research Biochemicals Inc. (Natick, MA, U.S.A.).
Tissue Preparation: Adult sheep pineal glands were generously provided by Dr
P.J.Morgan, Rowett Research Institute, Aberdeen, U.K. Glands were stored at -7oOc until used. Five pineals were homogenized in 10 volumes of ice-cold tris HCl buffer (50 mM, pH 7.40) containing 1 m phenylmethylsulfonyl fluoride (PMSF), 50 ug/ml leupeptin and 1 mM EGTA. The homogenate was centrifuged at 100,000 x g for 60 min. at 4Oc. Pellets (crude membranes) were washed twice with homogenization buffer and resuspended at a concentration of 1.67 mg/ml and stored at -7Q'C until used.
Binding Assay: Membranes (30 ~1, 50 1-19) were incubated with 50 ul of [3~1-~~~
in the absence (total binding) or presence (non specific binding) of 10 uM DTG (final concentration) in a total volume of 100 ~1. Kinetic and competition experiments used a concentration of 25 nM L3~1-D~c, and saturation experiments a range of concentrations between 0.625 and 160 Ml. After incubation for 30 min at 25OC in a water bath, 2 ml of ice-cold tris HCl was added and the contents of each tube rapidly filtered under vacuum through GF/C glass-fiber filters (Whatman, Maidstone, U.K.). Each filter was washed twice with 5 ml of ice-cold tris HCl and the radioactivity retained by the filter measured after addition of 4 ml of scintillation fluid (OptiPhase Safe, LKB, UK) on a LKB scintillation spectrometer (model 1219) at a counting efficiency of 55-60%.
876
Vol. 171, No. 2, 1990 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
The protein concentration in the membrane preparation was determined with a dye-binding method (12) using bovine serum albumin as a standard.
Data analysis:. Data from kinetic experiments were analyzed using pseudo
first-order equations to estimate the association rate constant (K ) and the dissociation rate constant (K ). Data from saturat!oL experiments were analyzed using ENZFITTAR (13).
IC50 values were determined from curves of inhibition of binding against drug concentration fitted using a weighted logit-log equation. Between 9 and 12 inhibitor concentrations were used. K. values + the standard error of the estimate for each inhibitoriwere then-determined from IC 5. values using the Cheng-Prusoff equation (14).
RESULTS AND DISCUSSION
Figure 1 shows that the association of L3H1-DTG to sheep pineal
membranes proceeded rapidly at 25OC reaching a plateau after
approximately 20 min. Dissociation was initiated after 70 minutes by
addition of DTG (10 )JM). Kinetic analysis of data from two experiments
gave a dissociation rate constant (K-,) of 0.0515 + 0.007 -1 min , and
an association rate constant (K+l ) of 0.00520 + 0.0005 nM-'.min-'. The
Kd (Kml,/K+,) value calculated from these constants was 9.90 + 1.6 nM.
Total and non specific binding of L3H1-DTG increased over the
range of concentrations (0.625-160 nM) of L381-~~c used, as shown for
a representative experiment in Figure 2. Specific binding accounted
for 82-86% of total binding. Scatchard analysis of the specific
binding data yielded a linear plot suggesting a single class of
0.6 - DTGt 1 OyM)
I/l.
\ *--a
--v
0 20 40 60 80 100 120
TIME (mid
Figure 1. Kinetics of association and dissociation of L3H1-DTG to sheep pineal membranes. s embrane suspension (50 !Jg protein/tube) was incubated with 25 nM [ HI-DTG at 25OC. Cold DTG (10 PM) was added at the arrow. The specific binding data shown is from a typical experiment. Each point represents the mean of duplicate determinations.
877
Vol. 171, No. 2, 1990 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
binding site for f3H1-DTG (Figure 3). Analysis of 3 independent
experiments gave a mean (2 S.E.M.) Kd of 27.0 + 1.0 nM, a maximal
number of binding sites (Bmax ) 1.39 + 0.03 pmol L3Hl-DTG/mg protein,
and a Hill coefficient (nH) 0.99 + 0.04. The Kd value from Scatchard
analysis and that calculated from the kinetic constants were similar,
and in close aggreement with the Kd (28 nM) reported for i3Hl-DTG
binding to guinea pig brain membranes (8). Binding of [‘)HI-DTG to
sheep pineal membranes was not inhibited by 1 mM GTP (data not shown).
In order to verify that 3 the [ HI-DTG binding site in pineal
membranes was a sigma site the ability of a number of drugs to compete
for ['HI-DTG binding was studied. The rank order of potency of drugs
for inhibiting the binding of [3~1-~~~ (25 nM) to sheep pineal
membranes was: trifluoperazine = DTG > haloperidol > pentazocine >
spiperone> imipramine> propranolol >desimipramine = (+)-3-PPP >
(+/-)SKF 10,047. The potency of these compounds in sheep pineal
membranes was similar to that reported for guinea pig brain membranes
(8).
_ 60.0 2.5
I
Total Binding
0 ? 2.0 - 60.0 .
gz ii * a7
r p 1.5 Specific Binding t- m .
CJ ! f 40.0 & 2 1.0
+ 5 0.5
* ; 20.0 .
Non Specific Binding z 0.0 -
0.0 0 500 1000 1600
0 0 100 200
2 0 3 BOUND 3H-DTG(nM) (fmol/mg. prot.)
Figure 2. Saturation isotherm of r3H1-DTG in sh$ep pineal membranes. Membranes (50 I.rg) were incubated at 25OC with [ HI-DTG (0.625-160 nM) for 30 minutes. Each value is the mean of duplicate determinations. A representative experiment is shown. Non specific binding (V) was determined in the presence of 10 PM DTG. Specific binding (0) was defined as total binding (0) minus non specific binding.
Figure 3. Scatchard plot of L3B1-DTG to sheep pineal membranes. A representative experiment is shown. For further details see legend to Figure 2 and Materials and Methods. Each value is the mean of duplicate determinations.
878
Vol. 171, No. 2, 1990 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
In our experiments haloperidol was slightly less potent than DTG.
However, the reduced metabolite of haloperidol (metabolite II),
recently shown to have a high affinity for sigma receptors but a much
lower affinity for the dopamine D 2
receptor (151, inhibited L3H]-DTG
binding to sheep pineal membranes (Table 1). The haloperidol
metabolite formed by oxidative N-dealkylation (metabolite I) was a
much weaker inhibitor (Table 1, 15).
Testosterone, progesterone and desoxycorticosterone, steroids
previously reported to have some affinity for the sigma site in brain
membranes and suggested to be potential endogenous ligands for the
sigma receptor (161, were very weak inhibitors of L3~1-~~c binding in
Table 1. Inhibition of specific [3Hl-DTG binding to sheep
pineal gland membranes
Compound Ki (nM)
Trifluoperazine 10.4 + 4.4 -
DTG 12.5 + 0.6 -
Haloperidol 49.2 2 3.4
Pentazocine 155.0 + 14.0 -
Haloperidol metabolite II 186.6 + 39.8 -
Spiperone 206.7 + 29.0
Imipramine 314.0 + 41.0
Propranolol 345.2 + 17.8
Desimipramine 790.0 2 161.0
(+)-3-PPP 812.0 + 34.0
(+/-JSKF 10,047 1017.4 2 290.9
Haloperidol metabolite I 1253.2 5 201.6
-
The concentration of incubation (25OC.
[3~1-~~~ used was 35 nM. The 30 min) was started by addition of [ HI-DTG and
terminated by filtration as described in Material and Methods. K. values (mean + the standard error of the estimate) were calculate a using the Chenq-Prusoff equation (14) from IC values obtained using a weighted logit-log analysis of competitio?' data. The following compounds caused no significant displacement at 10 UM: 5-HT. GABA, melatonin, phenylephr ine, isoprenaline, noradrenaline, dopamine, (+)pindolol, atenolol, yohimbine, practolol, salbutamol, methoxamine.
The K. values for clonidine, testosterone and desoxykorticosterone were >
progesterone, 10 PM.
879
Vol. 171, No. 2, 1990 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
the present experiments (Ki> 10 UM). Interestingly, these steroids
have been shown to inhibit B-adrenergic induction of sNAT activity
in the rat pineal gland in culture by an action at a site after cyclic
AMP generation (17) at concentrations similar to those reported to
inhibit binding of sigma receptor ligands in brain membranes (16). The
3 very weak inhibition of [ HI-DTG binding in sheep pineal membranes in
the present experiments suggests that it is unlikely that these
steroids inhibit b-adrenergic induction of sNAT activity by an action
on the sigma receptor.
The results confirm, and extend, a recent report (11) using an
autoradiographic method that sigma binding sites are highly
concentrated in the rat pineal gland. Our own preliminary work has
also identified specific L3~l-~TG binding sites in rat pineal
membranes (unpublished). It is not known if these binding sites are
located presynaptically in the sympathetic terminals which innervate
the pineal gland or postsynaptically on pinealocytes themselves. The
role of these binding sites, if any, in regulating pineal physiology
has yet to be determined. Interestingly, sigma liqands have been shown
to attenuate phosphatidylinositol turnover in rat brain synaptosomes
(18); such an action on pinealocytes might be expected to lead to an
inhibition of melatonin synthesis as an a1-
adrenergic activation of
phosphatidylinositol hydrolysis is involved in inducing sNAT activity
(1). In addition sigma liqands have been reported to increase
electrically evoked noradrenaline release from vas deferens (19). If
this effect was to occur in the pineal gland then adrenergic induction
of melatonin synthesis would be expected to be amplified by activation
of sigma receptors. The pineal gland may prove to be a useful model
system in which to study the intracellular signalling systems coupled
to sigma receptors.
ACKNOWLEDGMENTS
We would like to thank Dr P.J.Morqan for supplying sheep pineal glands and Nelson Chong for his help in preparing pineal membranes. P.A. was
880
Vol. 171, No. 2, 1990 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
supported by a postdoctoral visiting fellowship from the Government of the Canary Islands, Spain. The financial support of the Royal Society is gratefully acknowledged. DS is a Royal Society 1983 University Research Fellow.
REFERENCES
(1) Sugden,D. (1989) Experientia 3, 922-932. (2) Kaku,K., Inoue,Y., Matsutani,A., 0kubu.M.. Hatoo,K., Kaneki,T.,
and Yanaihara,N. (1983) Biomed.Res. 4, 321-328. (3) Yuwiler,A. (1983) J.Neurochem. 41, 146-153. (4) Simonneaux,V. Murrin,L.C. and Ebadi,M. (1990) J.Pharmacol.Exp.
Ther. 253, 214-220. (5) Sarda,N., Gharib,A., Reynaud,D., Ou,L. and Pacheco,H. (1989)
J.Neurochem. 53, 733-737. (6) Taylor,R.L., Albuquerque,M.L. and Burt,D.R. (1980) Life Sci. 2,
2195-2200.
(7) Matthew,E., Parfitt,A.G., Sugden,D., Engelhardt,D.L., Zimmerman, E.A. and Klein,D.C. (1984) J.Pharmacol.Exp.Ther. 228, 434-438.
(8) Weber, E., Sonders, M., Quarum, M., McLean, S., Pou, S. and Keana,J.F.W. (1986) Proc. Natl. Acad. Sci. U.S.A 83, 8784-8788.
(9) Largent,B.L., Gund1ach.A.L. and Snyder,S.H. (1986) J.Pharmacol. Exp.Ther. 238, 739-748.
(10) Gundlach,A.L., Largent,B.L. and Snyder,S.H. (1986) J.Neuroscience 5, 1757-1770.
(11) Jansen, K.L.R., Dragunow, M. and Faull, R.L.M. (1990) Brain Res. 507 --I 158-160.
(12) Bradford, M.M. (1976) Anal. Biochem. 72, 248-254. (13) Leatherbarrow, R.J. (1987) Elsevier-Biosoft, Cambridge, UK. (14) Cheng, Y. and Prusoff, W.H. (1973) Biochem. Pharmacol. 2,
3099-3108. (15) Bowen,W.D., Moses,E.L., Tolentin0,P.J. and Walker,J.M. (1990)
Eur.J.Pharmacol. 177, 111-118. (16) Su, T.P., London, E-D., Jaffe, J.H. (1988) Science 240, 219-230. (17) Yuwiler,A. (1989) J.Neurochem. z, 46-53. (18) Bowen,W.D., Kirschner,A.H., Newman,A.H. and Rice,K.C. (1988)
Eur.J.Pharmaco1.x. 399-400. (19) Campbell,B.G., Bobker,D.H., Les1ie.F.M.. Mefford,I.N. and
Weber,E. (1987) Eur.J.Pharmacol. 138, 447-448.
881